Neximmune Stock Price, News & Analysis
Company Description
Neximmune (OTC Link: NEXI) is a publicly traded biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $4.1M, ranking #6,851 among all listed U.S. companies by market cap.
NEXI stock has gained 0.0% over the past year. Shares last traded at $0.0001.
On a trailing twelve-month basis, Neximmune reported net income of -$32.3M and diluted earnings per share of $-30.82.
This page provides a comprehensive overview of NEXI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Neximmune (NEXI) stock last traded at $0.0001. At a market capitalization of $4.1M, NEXI is classified as a micro-cap stock with approximately 1.4M shares outstanding.
NEXI Rankings
Latest News
Neximmune has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include offering, partnership, stock split, earnings, clinical trial. View all NEXI news →
SEC Filings
Financial Highlights
operating income reached -$33.0M, and net income was -$32.3M. Diluted earnings per share stood at $-30.82. The company generated -$31.4M in operating cash flow. With a current ratio of 1.06, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in Neximmune (NEXI) currently stands at 112 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 97.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Neximmune (NEXI) currently stands at 1.0 days, down 75.9% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 42.5% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 365.8 days.
NEXI Company Profile & Sector Positioning
Neximmune (NEXI) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the OTC Link.
Investors comparing NEXI often look at related companies in the same sector, including Regenerx Biopharmaceuticals (RGRX), Eloxx Pharmaceut (ELOX), Gritstone Bio Inc (GRTSQ), Effector Therapeutics Inc (EFTR), and Innoveren Scientific Inc (IVRN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NEXI's relative position within its industry.